
zzso is a zzso of zzso which has a broad spectrum of zzso activity, both in zzso and in zzso Like zzso zzso is a selective inhibitor of the DNA zzso zzso zzso Phase I trials were conducted in Europe with the aim of determining the recommended zzso dose and schedule for evaluation in phase II zzso The phase I trials assessed the toxicity of zzso in 235 patients and tested three different administration zzso zzso was administered as a single infusion once every three weeks, as a weekly infusion for three weeks out of every four, and as a daily infusion for three consecutive days every three zzso The maximum tolerated dose zzso was 115 zzso in the daily schedule and 145 zzso in the weekly zzso When the drug was administered once every three weeks, zzso became the zzso toxicity at doses above 350 zzso This schedule allowed the highest dose intensity to be zzso was the best zzso and allowed zzso zzso Finally, using this schedule, a combination of zzso with high doses of zzso allowed the dose of zzso to be increased to 750 zzso An ongoing phase I trial is investigating the combination of zzso and zzso zzso in various solid zzso Although the zzso has not yet been reached, preliminary results have not demonstrated any zzso interaction between the two drugs, contrary to the findings of a previous Japanese zzso Based on the results of the three phase I trials, zzso administered at a dose of 350 zzso as an intravenous infusion over 30 minutes once every three weeks has been recommended for assessment in phase II zzso The phase II trials started in Europe at the beginning of zzso To date, zzso has showed remarkable efficacy in zzso cancer, even in patients resistant to zzso zzso results have also been obtained in zzso cervical and lung zzso Future trials will make it possible to assess whether there is a place for zzso in combination with other zzso agents or zzso 

